LRRK2 and Parkinson disease: More importantly, unlike other PD-related genes, hereditary and sporadic PD carrying LRRK2 mutations have a high degree of consistency in clinical characteristics and treatment response (Kett and Dauer, 2012; Tolosa et al., 2020).